# ATORVALIQ

NDC: 46287-030
Generic name: ATORVALIQ
Labeler / Manufacturer: CMP Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20230301

FDA application: NDA213260

## Active ingredients

- ATORVASTATIN CALCIUM TRIHYDRATE: 20 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46287-030"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46287-030
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=41fca2d8-7f3f-45b9-8974-81b89accc211